Rationale for Modernising Imaging in Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Rationale for Modernising Imaging in Advanced Prostate Cancer

Published:2017-04 Issue:2-3 Volume:3 Page:223-239
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Padhani Anwar R.,Lecouvet Frederic E.,Tunariu Nina,Koh Dow-Mu,De Keyzer Frederik,Collins David J.,Sala Evis,Fanti Stefano,Vargas H. Alberto,Petralia Giuseppe,Schlemmer Heinz Peter,Tombal Bertrand,de Bono Johann

Publisher

Elsevier BV

Subject

Urology

Reference125 articles.

1. Progress in emerging therapies for advanced prostate cancer;Oudard;Cancer Treat Rev,2013

2. Secondary hormonal therapy for advanced prostate cancer;Lam;J Urol,2006

3. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients;Bubendorf;Hum Pathol,2000

4. Burden of skeletal-related events in prostate cancer: unmet need in pain improvement;Broder;Support Care Cancer,2015

5. Clinical and economic burden of bone metastasis and skeletal-related events in prostate cancer;Yong;Curr Opin Oncol,2014

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-performing, Accessible, and Affordable Imaging in Metastatic Prostate Cancer: Is Whole-body Magnetic Resonance Imaging the Answer?;European Urology;2024-09

2. Evaluating the Initial Experience and Clinical Impact of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Scans in Prostate Cancer Management: A Retrospective Study in Iraq;Cureus;2024-08-26

3. Optimization and Stabilization of Automated Synthesis Systems for Reduced ⁶⁸Ga-PSMA-11 Synthesis Time;Korean Journal of Clinical Laboratory Science;2024-06-30

4. Deep learning assisted atlas-based delineation of the skeleton from Whole-Body Diffusion Weighted MRI in patients with malignant bone disease;Biomedical Signal Processing and Control;2024-06

5. True-Positive¹⁸F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study;Journal of Nuclear Medicine;2024-05-23